Argo Biopharma Reports Updated Phase 2 Data for BW...
Category : Clinical Trial Update 8 September 2026Investigational siRNA Therapy Shows Durable Reduction in HAE Attacks Argo Biopharmaceutical Co.,...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Tangram announces progression to patient cohorts i...
Category : Clinical Trial Update 7 September 2026Tangram Therapeutics (Tangram), a company committed to unlocking transformative RNAi medicines for m...
Clover Announces Positive Phase 2 Clinical Data fo...
Category : Clinical Trial Update 7 September 2026Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±P...
Inhibrx To Host Webcast Presentation to Provide Pr...
Category : Clinical Trial Update 7 September 2026Inhibrx Biosciences, Inc. (Nasdaq: INBX) (""Inhibrx"" or the ""Company...
Bayer Reports Positive Phase III Results for I-124...
Category : Clinical Trial Update 2 September 2026REVEAL Study Meets Primary Diagnostic Endpoints Bayer has announced the first detailed results fr...
Latest Newsletter Post
-
Argo Biopharma Reports Updated Phas..
8 September 2026
-
Inhibrx To Host Webcast Presentatio..
7 September 2026
-
Clover Announces Positive Phase 2 C..
7 September 2026
-
Tangram announces progression to pa..
7 September 2026
-
Novartis Reports Positive Phase III..
2 September 2026
